Overview

Dashboard News

new snb president highlights high geopolitical risks and subdued growth outlook
Martin Schlegel, the newly appointed president of the Swiss National Bank, addressed high geopolitical risks during his first speech in Bellinzona. He indicated that the bank anticipates subdued economic growth, projecting a GDP increase of only 1 percent for the year, which is below the long-term average. The visit to Ticino was met with pride from local officials, highlighting the significance of his new role.
TVS tvsvizzera.it
United States Dollar Swiss National Bank CHE Martin Schlegel Christian Vitta
TradFi, News Article
09:00 01.10.2024
us economy poised for roaring twenties amid risks and optimism
UBS suggests the U.S. economy is nearing a "Roaring '20s" revival, with a 50% chance of a booming cycle driven by strong GDP growth and manageable inflation. Despite concerns over rising unemployment and geopolitical risks, recent economic indicators support a positive outlook for the coming years.
Fortune
United States Dollar JPMorgan Chase & Co. UBS SA USA Jason Draho Jamie Dimon Jerome Powell Show more
TradFi, Market Report
09:00 01.10.2024
new snb chairman outlines economic outlook during first visit to ticino
Martin Schlegel, the new President of the Swiss National Bank (SNB), made his inaugural public appearance in Ticino, delivering a speech in Bellinzona. He highlighted significant geopolitical risks and projected moderate economic growth, with an expected GDP increase of 1% this year, below the long-term average. Christian Vitta, head of the Ticino Department of Finance and Economy, expressed the canton’s pride in hosting the SNB leader.
pme
United States Dollar Swiss National Bank CHE Martin Schlegel Christian Vitta
TradFi, News Article
09:00 01.10.2024
hospital consolidation raises concerns over costs and patient care quality
Nearly half of U.S. metropolitan areas are dominated by one or two health systems, raising concerns about rising healthcare costs and market competition. A recent study shows that 67% of hospitals were affiliated with health systems in 2022, with 97% of metro areas having highly concentrated hospital markets. While larger cities have more competition, major systems still control significant market shares, prompting increased scrutiny from Congress on hospital mergers and pricing policies.
Axios
HCA Healthcare, Inc. Ascension Health Alliance USA Sara Fischer Caitlin Owens Mark Thompson Show more
Regulatory & Legal, News Article
09:00 01.10.2024
Migros to close bestsmile locations amid restructuring and market challenges
Migros is set to close its dental care brand bestsmile, including its Lugano location, due to underperformance and a challenging market. The closure will occur in stages, affecting 27 locations and leading to job cuts, with a consultation process for impacted employees. Patients can continue their treatments at remaining bestsmile practices or at zahnarztzentrum.ch locations.
Corriere del Ticino
Migros Bank Medbase Group CHE
Finance & Economy, News Article
09:00 01.10.2024
doctors express concern over potential changes to pension tax rules
An NHS pension expert has reported receiving over 200 inquiries from healthcare professionals concerned about potential changes to pension tax rules following recent Budget discussions. Graham Crossley, director of MediFintech, noted that such rumors often prompt doctors to reconsider their retirement plans, particularly regarding tax-free lump sums and tax relief.
New Model Adviser
Medifintech Ltd. GBR Graham Crossley
Finance & Economy, News Article
09:00 01.10.2024
global telehealth market projected to reach 784 billion by 2032
Eli Lilly launched LillyDirect in January 2024, a digital healthcare platform targeting obesity and diabetes management. The global telehealth market is projected to grow from $84.4 billion in 2022 to $784.3 billion by 2032, driven by healthcare digitalization and increased patient engagement, despite challenges like behavioral interferences during remote monitoring. North America leads the market, while the Asia-Pacific region is expected to grow the fastest, highlighting significant opportunities for data analytics and improved patient outcomes.
ABN Newswire
United States Dollar Medtronic Defined Contribution Plan Master Trust Siemens Healthcare Private Limited Cerner Corporation (Oracle) Koninklijke Philips N.V. GE HealthCare Technologies Inc. HKG CAN GBR USA IND David Correa Joe Biden Show more
Technology & Innovation, Market Report
09:00 01.10.2024
uk artificial intelligence growth trends concerns and future outlook
Concerns about artificial intelligence are prevalent among 59% of Brits, with significant growth in the UK AI market, projected to reach £801.6 billion by 2035. The workforce in AI exceeds 360,000, contributing £3.7 billion to the economy, while job displacement could affect nearly 30% of roles in the next 20 years. Self-driving vehicles are expected on UK roads by 2025, despite 85% of the public expressing reservations about AI in cars.
Forbes Advisor UK
British Pound Sterling Marks and Spencer Group plc OpenAI Apple Inc. GBR Show more
Technology & Innovation, Market Report
09:00 01.10.2024
pediatric telemedicine market trends and growth opportunities through 2031
The Pediatric Telemedicine Market is experiencing significant growth, driven by advancements in technology and increasing demand for remote healthcare services. A recent report outlines key trends, market segmentation by type and application, and profiles major players like CISCO and Philips Healthcare. The study also provides forecasts and insights into regional market dynamics, highlighting opportunities for future development.
rock-news.at
McKesson Corporation AMD Global Telemedicine Cisco Systems, Inc. Polycom Corporation Aerotel Medical Systems Ltd DEU CHL ARG USA CAN JPN IND MEX COL GBR NGA FRA ESP KOR SAU CHN ITA Gauri Dabi Show more
Healthcare, Market Report
09:00 01.10.2024
big pharma's resilience amid biotech innovation and market challenges
Investors are evaluating biotech companies like Novo Nordisk, Merck, Pfizer, and Bayer, each with distinct strengths and vulnerabilities. Novo Nordisk focuses on diabetes and obesity, while Merck's Keytruda drives growth amid patent concerns. Pfizer aims to diversify beyond Covid-related products, and Bayer balances agricultural and pharmaceutical ventures, facing legal challenges from its Monsanto acquisition.
securities.io
United States Dollar Johnson & Johnson USA Show more
Finance & Economy, Market Report
09:00 01.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Central Bank Actions Market Sentiment Analysis Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Banking Regulations Inflation Rates & CPI Data Cryptocurrency & Blockchain Regulations Blockchain Technology Adoption Cryptocurrency Regulations Tokenomics and Crypto Economics Mergers & Acquisitions Cryptocurrency Developments Foreign Exchange Rates Market Analysis and Predictions Anti-Money Laundering (AML) Regulations Emerging Startups SEC & Financial Compliance
Countries:
USA CHE JPN CHN GBR DEU AUS IND KOR FRA HKG SGP TWN RUS ITA PRK CAN THA BRA ESP
Companies:
Coinbase Global, Inc. Apple Inc. BlackRock, Inc. Solana USD Ripples USD NVIDIA Corporation MicroStrategy Inc Credit Suisse Real Estate Fund Siat Tesla, Inc. Ethereum USD UBS Group AG MicroStrategy Incorporated Chainlink USD Nestlé S.A. Cardano USD Microsoft Corporation Fidelity Contrafund Kraken Energy Corp. VanEck Retail ETF End Federal Reserve USD
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen British Pound Sterling Australian Dollar Chinese Yuan Indian Rupee South Korean Won Canadian Dollar Colombian Peso Singapore Dollar Malaysian Ringgit Norwegian Krone Hong Kong Dollar Seychellois Rupee Philippine Peso Armenian Dram Russian Ruble Nigerian Naira
People:
Donald Trump Elon Musk Ali Martinez Jerome Powell Michael J. Saylor David O. Sacks Paul Atkins Joe Biden Bo Hines Charles Hoskinson Gary Gensler Sriram Krishnan Cynthia Lummis Brian Armstrong Wiley Nickel Patrick Hummel Justin Sun Richard Schueler Brian P. Brooks Paolo Ardoino

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings